Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Thorac Surg. 2017 Jul 29;104(4):1221–1230. doi: 10.1016/j.athoracsur.2017.05.011

Figure 3.

Figure 3

Survival for pN0 atypical carcinoids by use of adjuvant chemotherapy, NCDB 2006–2011

Estimate Overall Surgery Alone Adjuvant Chemo P value
12-month survival 96.5% (94.5–98.5%) 96.9% (95.1–98.8%) 86.7% (71.1–100%)
60-month survival 82.2% (77.5–87.2%) 82.6% (77.7–87.7%) 73.3% (54–99.5%)
Median survival NA months NA months NA months 0.087
NCDB National Cancer Data Base, pN0 pathologically node negative